Chronic inhibition of nitric oxide synthase (NOS) by NG-nitro-L-arginine methyl ester (L-NAME) is a well-established model of experimental hypertension and organ damage within the cardiovascular system [1,2,3] and kidney [4,5,6]. This evidence concerns the gene NOS2 and hypertensive disorder.